Key Metrics of NovoCure Limited
Revenue$509M▼ 5.3% YoYFY 2023
Operating income−$233M▼ 160.1% YoY
Net profit−$207M▼ 122.6% YoY
Shareholders' equity$362M
Market cap$1.5BNVCR · $13.11
Competitors10identified
About NovoCure Limited
Sectors
Company details
- Founded
- 2015
- Listed
- Nasdaq: NVCR (since 2015)
Operational Areas of NovoCure Limited
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameNovoCure Limited
TickerNVCR
ExchangeNasdaq
CountryJersey
SEC CIK0001645113
Listed since2015
IndustryMedical/Dental Instruments
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Website—
US market & SEC filings
NVCR · Nasdaq · SEC CIK 0001645113
Last price · 31 Oct 2026
$13.11
−7.48%
Market cap$1.5B
P/E—On FY 2023 diluted EPS
Volume5,956,150
SectorHealth CareMedical/Dental Instruments
Country · IPOJerseyListed 2015
NVCR share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered office—
GSTIN—
Email—
Website—
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of NovoCure Limited
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | hcahealthcare.com | 2011 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
Principal business activities and related-party transactions are read from MGT-7 and AOC-4 filings.
Filings
No filings on record yet.